chr2-165176265-CATT-C

Variant summary

Our verdict is Benign. The variant received -15 ACMG points: 1P and 16B. PM4_SupportingBP6_Very_StrongBA1

The NM_006922.4(SCN3A):​c.127_129delAAT​(p.Asn43del) variant causes a conservative inframe deletion change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0899 in 1,613,962 control chromosomes in the GnomAD database, including 7,425 homozygotes. Variant has been reported in ClinVar as Benign (★★). Synonymous variant affecting the same amino acid position (i.e. N43N) has been classified as Likely benign.

Frequency

Genomes: 𝑓 0.083 ( 641 hom., cov: 31)
Exomes 𝑓: 0.091 ( 6784 hom. )

Consequence

SCN3A
NM_006922.4 conservative_inframe_deletion

Scores

Not classified

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:6

Conservation

PhyloP100: 1.78

Publications

8 publications found
Variant links:
Genes affected
SCN3A (HGNC:10590): (sodium voltage-gated channel alpha subunit 3) Voltage-gated sodium channels are transmembrane glycoprotein complexes composed of a large alpha subunit with 24 transmembrane domains and one or more regulatory beta subunits. They are responsible for the generation and propagation of action potentials in neurons and muscle. This gene encodes one member of the sodium channel alpha subunit gene family, and is found in a cluster of five alpha subunit genes on chromosome 2. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jul 2008]
SCN3A Gene-Disease associations (from GenCC):
  • genetic developmental and epileptic encephalopathy
    Inheritance: AD Classification: DEFINITIVE Submitted by: Illumina, ClinGen
  • developmental and epileptic encephalopathy, 62
    Inheritance: AD Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
  • epilepsy, familial focal, with variable foci 4
    Inheritance: AD Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae), G2P
  • undetermined early-onset epileptic encephalopathy
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -15 ACMG points.

PM4
Nonframeshift variant in NON repetitive region in NM_006922.4. Strenght limited to Supporting due to length of the change: 1aa.
BP6
Variant 2-165176265-CATT-C is Benign according to our data. Variant chr2-165176265-CATT-C is described in ClinVar as Benign. ClinVar VariationId is 95444.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (NFE) allele frequency at 95% confidence interval = 0.0945 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
SCN3ANM_006922.4 linkc.127_129delAAT p.Asn43del conservative_inframe_deletion Exon 3 of 28 ENST00000283254.12 NP_008853.3

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
SCN3AENST00000283254.12 linkc.127_129delAAT p.Asn43del conservative_inframe_deletion Exon 3 of 28 1 NM_006922.4 ENSP00000283254.7

Frequencies

GnomAD3 genomes
AF:
0.0831
AC:
12627
AN:
152024
Hom.:
641
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.0590
Gnomad AMI
AF:
0.174
Gnomad AMR
AF:
0.0402
Gnomad ASJ
AF:
0.107
Gnomad EAS
AF:
0.00193
Gnomad SAS
AF:
0.0782
Gnomad FIN
AF:
0.182
Gnomad MID
AF:
0.0823
Gnomad NFE
AF:
0.0964
Gnomad OTH
AF:
0.0727
GnomAD2 exomes
AF:
0.0840
AC:
21119
AN:
251438
AF XY:
0.0873
show subpopulations
Gnomad AFR exome
AF:
0.0559
Gnomad AMR exome
AF:
0.0323
Gnomad ASJ exome
AF:
0.116
Gnomad EAS exome
AF:
0.00120
Gnomad FIN exome
AF:
0.178
Gnomad NFE exome
AF:
0.0965
Gnomad OTH exome
AF:
0.0872
GnomAD4 exome
AF:
0.0906
AC:
132502
AN:
1461820
Hom.:
6784
AF XY:
0.0911
AC XY:
66228
AN XY:
727214
show subpopulations
African (AFR)
AF:
0.0591
AC:
1978
AN:
33480
American (AMR)
AF:
0.0323
AC:
1446
AN:
44722
Ashkenazi Jewish (ASJ)
AF:
0.111
AC:
2907
AN:
26136
East Asian (EAS)
AF:
0.000579
AC:
23
AN:
39698
South Asian (SAS)
AF:
0.0856
AC:
7386
AN:
86256
European-Finnish (FIN)
AF:
0.178
AC:
9499
AN:
53420
Middle Eastern (MID)
AF:
0.0843
AC:
486
AN:
5768
European-Non Finnish (NFE)
AF:
0.0930
AC:
103413
AN:
1111946
Other (OTH)
AF:
0.0888
AC:
5364
AN:
60394
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.472
Heterozygous variant carriers
0
7177
14354
21532
28709
35886
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
3688
7376
11064
14752
18440
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0831
AC:
12636
AN:
152142
Hom.:
641
Cov.:
31
AF XY:
0.0850
AC XY:
6324
AN XY:
74364
show subpopulations
African (AFR)
AF:
0.0591
AC:
2453
AN:
41522
American (AMR)
AF:
0.0402
AC:
614
AN:
15290
Ashkenazi Jewish (ASJ)
AF:
0.107
AC:
370
AN:
3464
East Asian (EAS)
AF:
0.00212
AC:
11
AN:
5180
South Asian (SAS)
AF:
0.0783
AC:
377
AN:
4814
European-Finnish (FIN)
AF:
0.182
AC:
1922
AN:
10554
Middle Eastern (MID)
AF:
0.0816
AC:
24
AN:
294
European-Non Finnish (NFE)
AF:
0.0964
AC:
6556
AN:
68002
Other (OTH)
AF:
0.0715
AC:
151
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.499
Heterozygous variant carriers
0
566
1131
1697
2262
2828
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
146
292
438
584
730
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0994
Hom.:
157
Bravo
AF:
0.0707
Asia WGS
AF:
0.0350
AC:
122
AN:
3478
EpiCase
AF:
0.0901
EpiControl
AF:
0.0888

ClinVar

Significance: Benign
Submissions summary: Benign:6
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:3
Apr 20, 2017
Athena Diagnostics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Sep 09, 2022
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

See Variant Classification Assertion Criteria. -

Feb 04, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not specified Benign:1
May 09, 2013
Eurofins Ntd Llc (ga)
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Epilepsy, familial focal, with variable foci 4 Benign:1
Jul 15, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Developmental and epileptic encephalopathy, 62 Benign:1
Jul 15, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
PhyloP100
1.8
Mutation Taster
=66/34
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs72471101; hg19: chr2-166032775; COSMIC: COSV51804534; API